[Proceedings: Granulomatous hepatitis due to BCG during immunotherapy for malignant melanoma].
D001500:BCG Vaccine / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D006099:Granuloma / Q000209:etiology*; D006801:Humans; D007167:Immunotherapy; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged; D013899:Thoracic Neoplasms / Q000628:therapy*
D001500:BCG Vaccine
Hépatite granulomateuse par B.C.G. au cours d'une immunothérapie d'un mélanome malin